Lixisenatide in type 1 diabetes: A randomised control trial of the effect of lixisenatide on post‐meal glucose excursions and glucagon in type 1 diabetes patients

Lixisenatide in type 1 diabetes: A randomised control trial of the effect of lixisenatide on post‐meal glucose excursions and glucagon in type 1 diabetes patients

Aims The GLP1 agonist lixisenatide is glucagonostatic and reduces post‐prandial blood glucose (PPBG) in type 2 diabetes. This study investigates its impact in type 1 diabetes (T1D). <br></br> Methods In a blinded, crossover trial, 25 patients with T1D were randomised to 4 weeks adjunctiv...

Full description

Bibliographic Details
Main Authors:	Ballav, C, Dhere, A, Kennedy, I, Agbaje, O, Owen, K, White, S, Franklin, R, Hartman, B, Holst, J, Holman, J
Format:	Journal article
Language:	English
Published:	Wiley 2020

Similar Items

PROLONGED INFUSION OF GLUCAGON-LIKE PEPTIDE-1 IN TYPE-2 DIABETES NORMALIZES INSULIN-RESPONSE TO GLUCOSE
by: Gribble, F, et al.
Published: (1995)

Role of KATP channels in glucose-regulated glucagon secretion and impaired counterregulation in type 2 diabetes.
by: Zhang, Q, et al.
Published: (2013)

Glucagon like peptide-1 similarly amplifies insulin secretion in late-onset type 1 and type 2 diabetes
by: Maksoud, H, et al.
Published: (1999)

Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes
by: Kim, A, et al.
Published: (2021)

Predicting post one-year durability of glucose-lowering monotherapies in patients with new-onset type 2 diabetes
by: Agbaje, O, et al.
Published: (2017)

Type 1 and type 2 diabetes-chalk and cheese?
by: Owen, K, et al.
Published: (2009)

NON-SULFONYLUREA A4166 STIMULATES INSULIN IN TYPE-2 DIABETES AND REDUCES POSTPRANDIAL GLUCOSE EXCURSION BY 64-PERCENT
by: Levy, J, et al.
Published: (1995)

Risk of microvascular complications over 30 years in latent autoimmune diabetes of adults compared with type 2 diabetes
by: Maddaloni, E, et al.
Published: (2019)

Follow-up of Intensive Glucose Control in Type 2 Diabetes Reply
by: Holman, R, et al.
Published: (2009)

[Type 1 diabetes in children].
by: Ali, K, et al.
Published: (2011)

Type 1 diabetes in children
by: Ali, K, et al.
Published: (2011)

Type 1 diabetes in children.
by: Ali, K, et al.
Published: (2011)

Co-localisation of the Kir6.2/SUR1 channel complex with glucagon-like peptide-1 and glucose-dependent insulinotrophic polypeptide expression in human ileal cells and implications for glycaemic control in new onset type 1 diabetes.
by: Nielsen, L, et al.
Published: (2007)

Improving glucose control and cardiovascular risk in general practice Type 2 diabetes.
by: Potts, N, et al.
Published: (2003)

Optimizing blood glucose control in type 2 diabetes: an approach based on fasting blood glucose measurements.
by: Holman, R, et al.
Published: (1988)

Type 1 diabetes: a relatively unknown sibling of type 2 diabetes
by: Ahmad Mahfuz, Gazali
Published: (2021)

Effect of type 1 diabetes and type 2 diabetes on the risk of venous thromboembolism
by: Hinton, W, et al.
Published: (2020)

Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes.
by: Holman, R, et al.
Published: (2014)

Intensive glucose control and macrovascular outcomes in type 2 diabetes.
by: Turnbull, F, et al.
Published: (2009)

Effects of meals differing in glycemic index on postprandial glucose and insulin levels in individuals with and without type 2 diabetes mellitus
by: Lau, Zhi Ch'ng
Published: (2021)

10-year follow-up of intensive glucose control in type 2 diabetes.
by: Holman, R, et al.
Published: (2008)

Modelling incremental benefits on complications rates when targeting lower HbA1c levels in people with Type 2 diabetes and cardiovascular disease
by: Mostafa, SA, et al.
Published: (2017)

Development of type 1 diabetes mellitus blood glucose level simulation mobile application
by: Mohamad Akbar, Asyraf Aiman
Published: (2020)

Late onset type 1 diabetes.
by: Lasserson, D, et al.
Published: (2012)

Late onset type 1 diabetes
by: Lasserson, D, et al.
Published: (2012)

Type 1 diabetes: The theme for this edition
by: Narendran, P, et al.
Published: (2009)

Late onset type 1 diabetes.
by: Lasserson, D, et al.
Published: (2012)

Causal mechanisms in type 1 diabetes
by: Rubio Garcia, A
Published: (2022)

Glucose in glucagon release.
by: Rorsman, P, et al.
Published: (1990)

Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes--Authors' reply.
by: Holman, R, et al.
Published: (2014)

Postprandial glucose and its role in type 2 diabetes.
by: Davidson, J, et al.
Published: (2006)

Postprandial glucose and its role in type 2 diabetes.
by: Davidson, J, et al.
Published: (2006)

Do glycoalbumin levels preferentially reflect changes in postprandial glucose excursions?
by: Paul, S, et al.
Published: (2017)

Self-care behaviour and blood glucose control in young adults with type 1 diabetes mellitus.
by: Peveler, R, et al.
Published: (1993)

UKPDS58--modeling glucose exposure as a risk factor for photocoagulation in type 2 diabetes.
by: Stevens, R, et al.
Published: (2002)

Continuous glucose monitoring detected hypoglycaemia in the Treating to Target in Type 2 Diabetes Trial (4-T)
by: Levy, J, et al.
Published: (2017)

Treating young adults with type 2 diabetes or monogenic diabetes
by: Owen, K
Published: (2016)

Genetics of type 2 diabetes.
by: Owen, K, et al.
Published: (2007)

Insulin therapy in type II diabetes.
by: Holman, R, et al.
Published: (1995)

An updated review of type 1 diabetes in Malaysia
by: Ahmad Mahfuz, Gazali
Published: (2022)